Aarti Drugs Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue increased sharply in the latest quarter, indicating strong market demand.
Profit margins improved, showcasing better cost management and operational efficiency.
EPS growth signals enhanced shareholder value and profitability.

NEGATIVES

Expenses have risen consistently, suggesting potential cost pressures impacting profitability.
Net profit decreased in the latest quarter compared to the previous, raising concerns over sustainability.
Operating profit margins have shown volatility, indicating inconsistent performance.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	661.11	641.54	605.94	619.99	555.34	598.33	556.60	676.76	590.51
Expenses	577.04	565.09	535.80	534.18	490.38	531.28	494.87	583.44	516.43
Operating Profit	84.07	76.45	70.14	85.81	64.96	67.05	61.73	93.32	74.08
Other Income	0.60	0.68	1.67	1.08	1.11	1.48	11.90	1.87	0.31
Interest	8.54	8.25	7.60	9.13	8.71	8.93	9.07	9.16	8.56
Depreciation	12.60	12.61	12.66	13.58	13.38	13.72	13.80	14.88	14.72
Profit Before Tax	63.53	56.27	51.55	64.18	43.98	45.88	50.76	71.15	51.11
Tax	15.56	16.67	14.84	16.87	10.71	10.92	13.67	8.38	-2.86
Net Profit	47.97	39.60	36.71	47.31	33.27	34.96	37.09	62.77	53.97
Eps in Rs	5.18	4.29	3.99	5.15	3.62	3.83	4.06	6.88	5.91